Skip to main content
Clinical Trials/2026-525930-47-00
2026-525930-47-00
Recruiting
Phase 1

Pilot, randomized, crossover, comparative bioavailability study of two tadalafil formulations (oral suspension and film-coated tablets) after a single oral dose of 20 mg under fasting conditions in healthy male volunteers.

Farmalider S.A.0 sites8 target enrollmentStarted: May 1, 2026Last updated:

Overview

Phase
Phase 1
Status
Recruiting
Sponsor
Farmalider S.A.
Enrollment
8

Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 64 years (18-64 Years)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Farmalider S.A.
Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Carlos Calandria

Scientific

Farmalider S.A.

Similar Trials